Reported figures and Equlion model projections for the next 5 years.
ROE
+2.9 pt
Company
Sector average (own scale)
ROA
+3.3 pt
Company
Sector average
Gross Margin
+15.4 pt
Company
Sector average
Net Margin
+21.3 pt
Company
Total Assets
+59.6%
Company
Sector average
Net Income
+42.8%
Company
Sector average
Valuation
+456%
Company
Sector average
Amounts in TWD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Chunghwa Chemical Synthesis & Biotech Co., Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.